Direct Inhibition of Tumor Hypoxia Response with Synthetic Transcriptional Repressors
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 31 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 31 samples: 5 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Direct inhibition of tumor hypoxia response with synthetic transcriptional repressorsNature chemical biology · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE198157_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA813878 and SRA study SRP363057. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 19 samples.
How we read this: 5 replicated groups read from 31 sample titles; they account for 19 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM5939916 Normoxia replicate 1 Normoxia
- GSM5939917 Normoxia replicate 2 Normoxia
- GSM5939918 Normoxia replicate 3 Normoxia
- GSM5939922 Hypoxia replicate 1 Hypoxia
- GSM5939923 Hypoxia replicate 2 Hypoxia
- GSM5939924 Hypoxia replicate 3 Hypoxia
- GSM5939925 Hypoxia with STR22 replicate 1 Hypoxia with STR22
- GSM5939926 Hypoxia with STR22 replicate 2 Hypoxia with STR22
- GSM5939927 Hypoxia with STR22 replicate 3 Hypoxia with STR22
- GSM5939928 Replicate 1 normoxia input
- GSM5939929 Replicate 1 hypoxia input
- GSM5939930 Replicate 1 hypoxia with STR22 input
- GSM5939931 Replicate 1 normoxia IP
- GSM5939932 Replicate 1 hypoxia IP
- GSM5939933 Replicate 1 hypoxia with STR22 IP
- GSM5939934 Replicate 2 normoxia input
- GSM5939935 Replicate 2 hypoxia input
- GSM5939936 Replicate 2 hypoxia with STR22 input
- GSM5939937 Replicate 2 normoxia IP
- GSM5939938 Replicate 2 hypoxia IP
- GSM5939939 Replicate 2 hypoxia with STR22 IP
- GSM7713729 Mouse tumor PBS treatment #1 Mouse tumor PBS treatme…
- GSM7713730 Mouse tumor PBS treatment #2 Mouse tumor PBS treatme…
- GSM7713731 Mouse tumor PBS treatment #3 Mouse tumor PBS treatme…
- GSM7713732 Mouse tumor PBS treatment #4 Mouse tumor PBS treatme…
- GSM7713733 Mouse tumor PBS treatment #5 Mouse tumor PBS treatme…
- GSM7713734 Mouse tumor STR22 treatment #1 Mouse tumor STR22 treat…
- GSM7713735 Mouse tumor STR22 treatment #2 Mouse tumor STR22 treat…
- GSM7713736 Mouse tumor STR22 treatment #3 Mouse tumor STR22 treat…
- GSM7713737 Mouse tumor STR22 treatment #4 Mouse tumor STR22 treat…
- GSM7713738 Mouse tumor STR22 treatment #5 Mouse tumor STR22 treat…
- GSE63782 Transcriptional plasticity promotes primary and acquired resistance to BET bromodomain inhibition 103 samples shares inhibition
- GSE41747 MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors, despite transcriptional feedback onto ERK. 83 samples shares inhibition
- GSE294573 HNF4a controls growth, identity and response to KRAS inhibition in IMA. 60 samples shares inhibition
- GSE71403 Tumor hypoxia causes DNA hypermethylation by reducing TET activity 99 samples shares hypoxia
- GSE316054 Targeting the ADAR1 p150 isoform triggers tumor growth inhibition and antitumor immunity to overcome immunotherapy resistance 52 samples shares inhibition
- GSE99063 CDK4/6 inhibition and tumor immunity 45 samples shares inhibition
- GSE266956 Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer 42 samples shares synthetic
- GSE283902 Hydroxychloroquine prevents resistance and potentiates antitumor effect of SHP2 inhibition in NF1-associated Malignant Peripheral Nerve Sheath Tumors 31 samples shares inhibition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.